Is Ascentage Pharma Group International (AAPG) a Buy, Sell, or Hold?
Ascentage Pharma Group International
NASDAQ:AAPG
$20.18 USD
$0.94 (4.89%)
- Volume
- 15.21K
- Average Volume
- 10.98K
- Market Capitalization
- $1.88B
- P/E Ratio
- -9.85
- Dividend Yield
- 0.00%
- Price Target
- $40.00
- Year High
- $48.45
- Year Low
- $16.36
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.79
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
21
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
2
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$ 188.32K
AAPG Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
AAPG Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Miyara Faical | 2026-06-25 | 0 | 2026-06-29 | ||
| Zhai Yifan | officer: Chief Medical Officer | 2026-05-21 | M-Exempt | 0 | 2026-05-22 |
| Zhai Yifan | officer: Chief Medical Officer | 2026-05-21 | M-Exempt | 0 | 2026-05-22 |
| Zhai Yifan | officer: Chief Medical Officer | 2026-05-20 | A-Award | 0 | 2026-05-22 |
| Zhai Yifan | officer: Chief Medical Officer | 2026-05-20 | A-Award | 6.58 | 2026-05-22 |
| Zhai Yifan | officer: Chief Medical Officer | 2026-05-20 | A-Award | 0 | 2026-05-22 |
| Zhai Yifan | officer: Chief Medical Officer | 2026-05-20 | A-Award | 6.58 | 2026-05-22 |
| Zhai Yifan | officer: Chief Medical Officer | 2026-05-20 | A-Award | 0 | 2026-05-22 |
| Zhai Yifan | officer: Chief Medical Officer | 2026-05-20 | A-Award | 8.12 | 2026-05-22 |
| Zhai Yifan | officer: Chief Medical Officer | 2026-05-20 | A-Award | 0 | 2026-05-22 |
| Zhai Yifan | officer: Chief Medical Officer | 2026-05-20 | A-Award | 0 | 2026-05-22 |
| Zhai Yifan | officer: Chief Medical Officer | 2026-05-21 | M-Exempt | 0 | 2026-05-22 |
| Yang Dajun | director, officer: Chairman and CEO | 2026-05-21 | M-Exempt | 0 | 2026-05-22 |
| Yang Dajun | director, officer: Chairman and CEO | 2026-05-21 | M-Exempt | 0 | 2026-05-22 |
| Yang Dajun | director, officer: Chairman and CEO | 2026-05-20 | A-Award | 6.58 | 2026-05-22 |
| Yang Dajun | director, officer: Chairman and CEO | 2026-05-20 | A-Award | 0 | 2026-05-22 |
| Yang Dajun | director, officer: Chairman and CEO | 2026-05-20 | A-Award | 6.58 | 2026-05-22 |
| Yang Dajun | director, officer: Chairman and CEO | 2026-05-20 | A-Award | 0 | 2026-05-22 |
| Yang Dajun | director, officer: Chairman and CEO | 2026-05-20 | A-Award | 8.12 | 2026-05-22 |
| Yang Dajun | director, officer: Chairman and CEO | 2026-05-20 | A-Award | 0 | 2026-05-22 |
| Yang Dajun | director, officer: Chairman and CEO | 2026-05-20 | A-Award | 0 | 2026-05-22 |
| Yang Dajun | director, officer: Chairman and CEO | 2026-05-20 | A-Award | 0 | 2026-05-22 |
| Yang Dajun | director, officer: Chairman and CEO | 2026-05-21 | M-Exempt | 0 | 2026-05-22 |
| Misra Veet | officer: Chief Financial Officer | 2026-04-20 | A-Award | 0 | 2026-04-21 |
| Misra Veet | 2026-03-18 | 0 | 2026-04-21 | ||
| Cao Jin | officer: Chief Accounting Officer | 2026-03-18 | 0 | 2026-04-20 | |
| Cao Jin | officer: Chief Accounting Officer | 2026-03-18 | 0 | 2026-04-10 | |
| Zhai Yifan | officer: Chief Medical Officer | 2026-03-18 | 0 | 2026-03-23 | |
| Zhai Yifan | officer: Chief Medical Officer | 2026-03-18 | 0 | 2026-03-23 | |
| Zhai Yifan | officer: Chief Medical Officer | 2026-03-18 | 0 | 2026-03-23 | |
| Zhai Yifan | officer: Chief Medical Officer | 2026-03-18 | 0 | 2026-03-23 | |
| Zhai Yifan | officer: Chief Medical Officer | 2026-03-18 | 8.14 | 2026-03-23 | |
| Zhai Yifan | officer: Chief Medical Officer | 2026-03-18 | 0 | 2026-03-23 | |
| Wei Ren | director | 2026-03-18 | 0 | 2026-03-23 | |
| Wei Ren | director | 2026-03-18 | 8.14 | 2026-03-23 | |
| Wei Ren | director | 2026-03-18 | 0 | 2026-03-23 | |
| Ye Changqing | director | 2026-03-18 | 0 | 2026-03-23 | |
| Ye Changqing | director | 2026-03-18 | 0 | 2026-03-23 | |
| Yu Debra | director | 2026-03-18 | 0 | 2026-03-23 | |
| Lu Simon Dazhong | director | 2026-03-18 | 0 | 2026-03-23 | |
| Lu Simon Dazhong | director | 2026-03-18 | 0 | 2026-03-23 | |
| SIDRANSKY DAVID | director | 2026-03-18 | 0 | 2026-03-23 | |
| SIDRANSKY DAVID | director | 2026-03-18 | 0 | 2026-03-23 | |
| Wang Shaomeng | director | 2026-03-18 | 0 | 2026-03-23 | |
| Wang Shaomeng | director | 2026-03-18 | 0 | 2026-03-23 | |
| Wang Shaomeng | director | 2026-03-18 | 0 | 2026-03-23 | |
| Wang Shaomeng | director | 2026-03-18 | 8.14 | 2026-03-23 | |
| Wang Shaomeng | director | 2026-03-18 | 0 | 2026-03-23 | |
| LIPPMAN MARC E | director | 2026-03-18 | 0 | 2026-03-23 | |
| Knapp Thomas J | officer: SVP/General Counsel | 2026-03-18 | 0 | 2026-03-23 | |
| Knapp Thomas J | officer: SVP/General Counsel | 2026-03-18 | 8.14 | 2026-03-23 | |
| Knapp Thomas J | officer: SVP/General Counsel | 2026-03-18 | 0 | 2026-03-23 | |
| Bozilenko Marina | director | 2026-03-18 | 0 | 2026-03-23 | |
| Ye Changqing | director | 2026-03-18 | 8.14 | 2026-03-19 | |
| Ye Changqing | director | 2026-03-18 | 0 | 2026-03-19 | |
| Bozilenko Marina | director | 2026-03-18 | 8.14 | 2026-03-19 | |
| Bozilenko Marina | director | 2026-03-18 | 0 | 2026-03-19 | |
| Yang Dajun | director, officer: Chairman and CEO | 2026-03-18 | 0 | 2026-03-19 | |
| Yang Dajun | director, officer: Chairman and CEO | 2026-03-18 | 0 | 2026-03-19 | |
| Yang Dajun | director, officer: Chairman and CEO | 2026-03-18 | 0 | 2026-03-19 | |
| Yang Dajun | director, officer: Chairman and CEO | 2026-03-18 | 0 | 2026-03-19 | |
| Yang Dajun | director, officer: Chairman and CEO | 2026-03-18 | 8.14 | 2026-03-19 | |
| Yang Dajun | director, officer: Chairman and CEO | 2026-03-18 | 0 | 2026-03-19 | |
| SIDRANSKY DAVID | director | 2026-03-18 | 8.14 | 2026-03-19 | |
| SIDRANSKY DAVID | director | 2026-03-18 | 0 | 2026-03-19 | |
| Lu Simon Dazhong | director | 2026-03-18 | 8.14 | 2026-03-19 | |
| Lu Simon Dazhong | director | 2026-03-18 | 0 | 2026-03-19 | |
| LIPPMAN MARC E | director | 2026-03-18 | 0 | 2026-03-19 | |
| LIPPMAN MARC E | director | 2026-03-18 | 8.14 | 2026-03-19 | |
| LIPPMAN MARC E | director | 2026-03-18 | 0 | 2026-03-19 | |
| Yu Debra | director | 2026-03-18 | 8.14 | 2026-03-19 | |
| Yu Debra | director | 2026-03-18 | 0 | 2026-03-19 |